Literature DB >> 22181040

Phosphorylation and cleavage of the family of collapsin response mediator proteins may play a central role in neurodegeneration after CNS trauma.

Kasra Taghian1, Jae Young Lee, Steven Petratos.   

Abstract

The family of the collapsin response mediator proteins (CRMPs) plays a significant physiological role in neuronal cell bodies and axons within the integrated mammalian central nervous system (CNS). Trauma-induced damage to the CNS results in variable degrees of axonal degeneration, and this may lead to neuronal cell death in key grey matter regions. Site-specific phosphorylation of certain CRMPs has been associated with trauma-induced axonal degeneration. Moreover, recent data implicate the pro-apoptotic, calcium-dependent protease calpain as a key initiator of CRMP cleavage. The primary cleavage product of injury-induced neuronal calpain activation is a C-terminus truncated 55- to 58-kDa form of CRMP, which may exert its effects within the cytoplasm and axonal core, or alternatively through its translocation into the nucleus, initiating neuronal cell death. The precise structure of cleaved CRMP has yet to be elucidated, as is the reason for nuclear translocation. Once the crystal structure of the cytoplasmic and nuclear-translocated forms of CRMPs is determined, a greater molecular understanding of why these forms can initiate neurodegeneration following CNS injury will be established. Such information will be particularly informative in the design of inhibitors of specific protein-protein interaction sites between cleaved CRMP and vital cytosolic or nuclear molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22181040     DOI: 10.1089/neu.2011.2063

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  13 in total

1.  Postnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain.

Authors:  Atsuhiro Tsutiya; Ritsuko Ohtani-Kaneko
Journal:  J Anat       Date:  2012-07-22       Impact factor: 2.610

2.  Vertebrate paralogous CRMPs in nervous system: evolutionary, structural, and functional interplay.

Authors:  Yanyan Tang; Ziming Ye; Yunfei Wei; Cuiting Lin; Yongbo Wang; Chao Qin
Journal:  J Mol Neurosci       Date:  2014-06-05       Impact factor: 3.444

3.  Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Authors:  Steven Petratos; Ezgi Ozturk; Michael F Azari; Rachel Kenny; Jae Young Lee; Kylie A Magee; Alan R Harvey; Courtney McDonald; Kasra Taghian; Leon Moussa; Pei Mun Aui; Christopher Siatskas; Sara Litwak; Michael G Fehlings; Stephen M Strittmatter; Claude C A Bernard
Journal:  Brain       Date:  2012-04-28       Impact factor: 13.501

4.  Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.

Authors:  Jae Young Lee; Min Joung Kim; Speros Thomas; Viola Oorschot; Georg Ramm; Pei Mun Aui; Yuichi Sekine; Devy Deliyanti; Jennifer Wilkinson-Berka; Be'eri Niego; Alan R Harvey; Paschalis Theotokis; Catriona McLean; Stephen M Strittmatter; Steven Petratos
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

Review 5.  CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury.

Authors:  Jun Nagai; Rina Baba; Toshio Ohshima
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

6.  Increased Levels of Circulating Glial Fibrillary Acidic Protein and Collapsin Response Mediator Protein-2 Autoantibodies in the Acute Stage of Spinal Cord Injury Predict the Subsequent Development of Neuropathic Pain.

Authors:  Georgene W Hergenroeder; John B Redell; H Alex Choi; Lisa Schmitt; William Donovan; Gerard E Francisco; Karl Schmitt; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2018-07-05       Impact factor: 5.269

7.  Structure of human collapsin response mediator protein 1: a possible role of its C-terminal tail.

Authors:  Szu Heng Liu; Shih Fang Huang; Yuan Ling Hsu; Szu Hua Pan; Yen Ju Chen; Yi Hung Lin
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-07-28       Impact factor: 1.056

8.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01

9.  Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse.

Authors:  Kathleen M Schoch; Catherine R von Reyn; Jifeng Bian; Glenn C Telling; David F Meaney; Kathryn E Saatman
Journal:  J Neurochem       Date:  2013-02-03       Impact factor: 5.372

Review 10.  Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

Authors:  Jae Young Lee; Kasra Taghian; Steven Petratos
Journal:  Acta Neuropathol Commun       Date:  2014-08-27       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.